( May 20, 2026, 3:32 PM EDT) -- SINGAPORE — A Singapore Court of Appeal panel said a judge’s worldwide freezing order against all assets belonging to a Singaporean bioscience company and its founder pending arbitration by a Danish drug company over a drug investment dispute was proper, given evidence that the Danish company did not receive full disclosures about studies of a hypertension and kidney disease drug before investing more than $700 million....